Browse by author
Lookup NU author(s): Dr Mauro Santibanez Koref
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
O6-alkylguanine-DNA alkyltransferase (MGMT) represents the first line of defense against the toxic, mutagenic and carcinogenic effects of O 6-alkylguanine adducts in DNA. These adducts mediate the biological activity from a series of alkylating agents, such as the tobacco-specific nitrosamines, believed to contribute to the carcinogenicity of tobacco smoke. There have been conflicting reports on the effects of smoking on MGMT activity in lung and other tissues. Here, we investigate MGMT activity in peripheral blood mononuclear cells (PBMC) and lung bronchial epithelial cells (BEC), extracted by lung brushings, from smokers and nonsmokers attending a bronchoscopy clinic. MGMT activity was significantly lower in BECs (geometric mean; 95% confidence interval 1.02; 0.86-1.20 fmol/μg DNA) than in PBMCs (7.86; 6.70-9.59 fmol/μg DNA; p < 0.001), suggesting that bronchial epithelia may be particularly sensitive to alkylation damage. More importantly our results indicate that activity in BECs is significantly decreased in samples from current smokers (0.71; 0.54-0.93 fmol/μg DNA) compared to nonsmokers (1.25; 1.03-1.51 fmol/μg DNA; p = 0.002). This could represent an important contribution to the carcinogenicity of tobacco smoke. © 2006 Wiley-Liss, Inc.
Author(s): Povey AC, O'Donnell P, Barber P, Watson M, Margison GP, Santibanez Koref MF
Publication type: Article
Publication status: Published
Journal: International Journal of Cancer
Year: 2006
Volume: 119
Issue: 2
Pages: 463-466
ISSN (print): 0020-7136
ISSN (electronic): 1097-0215
Publisher: John Wiley & Sons, Inc.
URL: http://dx.doi.org/10.1002/ijc.21790
DOI: 10.1002/ijc.21790
PubMed id: 16477630
Altmetrics provided by Altmetric
